Exosomes are tiny membrane-enclosed packages, roughly 30 to 100 nanometers across, that virtually every cell in your body releases into its surroundings. They form inside compartments called multivesicular bodies, and when those compartments fuse with the cell’s outer membrane, the exosomes spill into the space between cells and into body fluids like blood, urine, saliva, and cerebrospinal fluid. Their function is communication: exosomes shuttle proteins, fats, and RNA from one cell to another, influencing everything from immune responses and tissue repair to cancer spread and neurodegenerative disease. What once looked like cellular garbage has turned out to be one of the body’s most versatile messaging systems.
How Exosomes Form Inside a Cell
The process starts at the cell surface. When a cell pulls material inward through its membrane, it creates small internal compartments called early endosomes. As these mature, portions of their limiting membrane bud inward, forming even smaller vesicles that accumulate inside the compartment. At this stage, the compartment is called a multivesicular body because it is literally a body filled with many vesicles. Those internal vesicles are the future exosomes. When the multivesicular body migrates to the cell surface and fuses with the plasma membrane, its contents are dumped outside the cell. The released vesicles are now exosomes.
1Journal of Lipid Research. Cholesterol and the journey of extracellular vesiclesThis distinguishes exosomes from a related class of particles called microvesicles, which form differently. Microvesicles bud directly outward from the cell’s surface membrane, pinching off like soap bubbles. Because of this distinct origin, exosomes tend to be smaller and carry a somewhat different molecular signature than microvesicles, though in practice the two overlap enough that separating them cleanly in the lab remains a persistent headache.
2PubMed. Extracellular Vesicles: Exosomes and Microvesicles, Integrators of HomeostasisThe Molecular Machinery Behind Exosome Birth
Two main pathways drive the inward budding that creates exosomes inside multivesicular bodies. The first involves a set of protein complexes collectively known as the ESCRT machinery. These complexes recognize tagged cargo on the endosomal membrane, cluster it together, and physically reshape the membrane to form the inward buds that become vesicles. When researchers systematically silenced individual ESCRT components, they found that knocking down certain ones reduced exosome release, while knocking down others had no effect or even increased it, revealing that different parts of the machinery contribute in distinct and sometimes counterintuitive ways.
3PubMed. Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesiclesThe second pathway bypasses the ESCRT system entirely. A landmark study showed that the lipid ceramide can drive exosome formation on its own. Ceramide, generated by an enzyme that cleaves a common membrane fat, changes the physical properties of the membrane in ways that promote spontaneous inward budding. Blocking the enzyme reduced exosome release, while the exosomes themselves turned out to be enriched in ceramide.
4PubMed. Ceramide triggers budding of exosome vesicles into multivesicular endosomesThat cells maintain at least two independent mechanisms for making exosomes hints at how important the process is. It also means that exosomes produced through different pathways can carry different cargo and serve different purposes, even when they come from the same cell.
5PubMed Central. Accessory ESCRT-III proteins are conserved and selective regulators of Rab11a-exosome formationWhat Exosomes Carry
An exosome is not an empty bubble. It contains a curated selection of proteins, messenger RNAs, microRNAs, and lipids drawn from its parent cell. The word “curated” matters here: the contents are not random. Cells actively sort specific molecules into exosomes while keeping others out, and the sorting mechanisms have been a major focus of research.
6PubMed Central. Sorting it out: regulation of exosome loadingFor RNA, one proposed mechanism involves physical affinity. Certain RNAs bind preferentially to lipid-rich regions on the outer surface of the multivesicular body membrane, and this binding determines which RNAs get swept into the forming vesicles.
7PubMed. Mechanisms of RNA loading into exosomesMicroRNAs, which are short RNA sequences that can silence genes in recipient cells, appear to be sorted by specific sequence motifs. Researchers identified a four-letter motif (GGAG) that is overrepresented in microRNAs found in exosomes. When they mutated a cellular microRNA to carry that motif, it became preferentially loaded into exosomes. Conversely, converting the motif in an exosomal microRNA to a cell-retention motif kept it inside the cell. A protein called hnRNPA2B1, in a chemically modified form, recognizes these motifs and directs the sorting.
8Nature Communications. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifsThis selectivity is what makes exosomes so biologically potent. A cancer cell does not just leak generic cellular material; it packages specific growth-promoting signals. An immune cell packages specific inflammatory or anti-inflammatory cues. The exosome is a message, not random noise.
How Exosomes Reach and Enter Other Cells
Once released, exosomes travel through body fluids and eventually dock onto target cells. The docking involves surface proteins on both the exosome and the recipient cell, giving the interaction a degree of specificity. After binding, the exosome is typically pulled inside the target cell through the same endocytic pathway that brought material into the original cell. But getting inside is only half the job. The exosome’s cargo needs to escape the endosome and reach the cell’s interior to have any effect.
Research using fluorescent tracking has shown that a fraction of internalized exosomes fuse with the inner wall of the endosome in an acid-dependent process, releasing their cargo into the cell’s main compartment. Without that acidification step, the cargo stays trapped and is eventually degraded.
9PubMed Central. Endocytosis of Extracellular Vesicles and Release of Their Cargo from EndosomesThe release of exosomes is itself regulated. Proteins in the RAB GTPase family, along with cytoskeletal components and docking proteins called SNAREs, control whether multivesicular bodies fuse with the plasma membrane or are instead routed to lysosomes for destruction. Under stress, infection, or genetic mutation, this balance shifts, changing how many exosomes a cell secretes and what they contain.
10Genes & Diseases. The biogenesis and secretion of exosomes and multivesicular bodies (MVBs): Intercellular shuttles and implications in human diseasesExosomes and the Immune System
Immune cells are prolific exosome producers. Dendritic cells, macrophages, T cells, and B cells all release exosomes that carry immune-relevant molecules, including fragments of foreign proteins displayed on their surfaces. These exosome-borne fragments can activate or suppress other immune cells at a distance, effectively extending immune signaling beyond direct cell-to-cell contact.
The immunological activities are broad: exosomes can enhance the presentation of foreign material to T cells, activate inflammatory pathways, or suppress immune responses depending on their cellular origin and cargo.
11Seminars in Cell & Developmental Biology. Exosomes and their roles in immune regulation and cancerDuring infections, exosomes participate in the back-and-forth between host and pathogen. They transfer pathogen-derived molecules between cells, which can prime distant immune cells for a faster response. But the same transfer can also spread virulence factors that help the pathogen evade immunity, making exosomes a double-edged sword in infectious disease.
12PubMed Central. The emerging role of exosomes in innate immunity, diagnosis and therapyTissue Repair and Regenerative Medicine
Much of the excitement around stem cell therapy in recent years has quietly shifted toward the exosomes that stem cells produce rather than the stem cells themselves. Mesenchymal stem cells, found in bone marrow, fat, and other tissues, release exosomes packed with growth factors, anti-inflammatory molecules, and regulatory RNAs. Studies in animals have shown that these exosomes can promote blood vessel formation, reduce inflammation, and stimulate tissue repair in the kidney, liver, heart, nervous system, and musculoskeletal system.
13PubMed Central. Mesenchymal stem cell-derived exosomes: Toward cell-free therapeutic strategies in regenerative medicineThe appeal is practical: exosomes are far easier to store, standardize, and administer than living cells. They do not replicate, so there is no risk of uncontrolled cell growth. And because they carry many of the same bioactive molecules their parent cells produce, they can mimic the therapeutic effect of a stem cell transplant without the transplant. Early work suggests that exosomes from various stem cell types, including embryonic, neural, and blood-forming stem cells, may be applicable across surgical and medical specialties from orthopedics to ophthalmology.
14Signal Transduction and Targeted Therapy. Clinical applications of stem cell-derived exosomesIn the wound healing context, mesenchymal stem cell exosomes have demonstrated the ability to modulate the local environment around injured tissue, dampening excessive inflammation during the acute phase while encouraging resident progenitor cells to kick-start repair.
15Frontiers in Cell and Developmental Biology. Role of MSC-derived small extracellular vesicles in tissue repair and regenerationHow Cancer Hijacks Exosomes
If exosomes are messages, tumors are prolific and manipulative writers. Cancer cells release exosomes that reshape distant tissues into environments hospitable to incoming tumor cells, a concept called the pre-metastatic niche. Tumor-derived exosomes can suppress immune surveillance at a distant organ, promote the growth of new blood vessels, and remodel the tissue’s structural scaffolding, all before a single cancer cell arrives.
16PubMed Central. The Key Role of Exosomes on the Pre-metastatic Niche Formation in TumorsThe role is multifaceted. Tumor exosomes carry inflammatory signals, angiogenic factors, and matrix-remodeling enzymes. They also display surface molecules that direct them to particular organs, which may help explain why certain cancers preferentially spread to specific locations.
17PubMed Central. Effects of exosomes on pre-metastatic niche formation in tumorsExosomes also contribute to drug resistance. By shuttling resistance-conferring molecules from drug-resistant cells to sensitive ones, they can spread resistance throughout a tumor population without any genetic mutation taking place.
18PubMed Central. The role of exosomes in liquid biopsy for cancer diagnosis and prognosis predictionExosomes in Neurodegenerative Disease
The same cell-to-cell transfer that makes exosomes useful in immunity and repair becomes dangerous in the brain. In Alzheimer’s disease, Parkinson’s disease, and prion disease, misfolded proteins that drive neurodegeneration have been found inside exosomes. The concern is that exosomes act as vehicles for spreading toxic protein aggregates from one neuron to the next, seeding the progressive pattern of damage seen in these conditions.
19PubMed Central. Focus on Extracellular Vesicles: Exosomes and Their Role in Protein Trafficking and Biomarker Potential in Alzheimer’s and Parkinson’s DiseaseResearch on tau protein, a hallmark of Alzheimer’s disease, has shown that neurons release tau via exosomes, and that this release increases when neurons are more active. Using specialized devices that mimic connected neural circuits, researchers demonstrated that exosomes can carry tau across synaptic connections from one neuron to another. In human cerebrospinal fluid from Alzheimer’s patients, exosomes containing both single tau molecules and clumped forms were found, and those exosomes could promote tau aggregation in cultured cells.
20PubMed Central. The release and trans-synaptic transmission of Tau via exosomesMore broadly, age-related decline in the cell’s protein quality control systems may push more misfolded proteins into the exosome pathway. When a cell cannot properly degrade a damaged protein internally, packaging it into exosomes and ejecting it becomes a relief valve, but one that shifts the burden to neighboring cells.
21PubMed Central. Exosomes in the Pathology of Neurodegenerative DiseasesExosomes as Diagnostic Tools
Because exosomes circulate in blood, urine, and other accessible fluids, and because their cargo reflects the state of the cells that produced them, they have attracted enormous interest as biomarkers. The idea behind “liquid biopsy” is straightforward: instead of surgically removing a piece of tumor to analyze it, draw a blood sample and examine the exosomes floating in it. Tumor-derived exosomes carry tumor-specific RNA, protein, and DNA that can reveal the cancer’s type, stage, and molecular characteristics.
MicroRNAs within exosomes are especially promising because they remain stable in body fluids, protected from degradation by the exosome’s lipid shell. Panels of exosomal microRNAs are being explored as early-detection tools for multiple cancers.
22PubMed Central. Liquid biopsy: Exosomal microRNAs as novel diagnostic and prognostic biomarkers in cancerBeyond microRNAs, exosomal messenger RNAs and long non-coding RNAs have also shown diagnostic potential. For colorectal cancer, for instance, a panel combining two messenger RNAs and one long non-coding RNA from exosomes has been proposed as a diagnostic candidate.
23Signal Transduction and Targeted Therapy. Application of exosomes as liquid biopsy in clinical diagnosisThe appeal goes beyond cancer. Exosomes containing neurodegenerative-disease proteins in cerebrospinal fluid or even blood could theoretically serve as early markers for Alzheimer’s or Parkinson’s, though this work is at an earlier stage.
Engineered Exosomes for Drug Delivery
If exosomes naturally carry molecules between cells and can cross biological barriers that stop most drugs, why not load them with therapeutics on purpose? That question has spawned a growing subfield. Researchers are using techniques like electroporation, sonication, and chemical surface modification to load exosomes with drugs, therapeutic RNAs, and proteins that would otherwise never reach their targets.
24PubMed Central. Exosomes as nanocarriers for brain-targeted delivery of therapeutic nucleic acids: advances and challengesThe brain is a particularly attractive target. The blood-brain barrier blocks the vast majority of drugs from entering the central nervous system, but exosomes from certain cell types show some natural ability to cross it. Engineering their surfaces with targeting molecules enhances that ability, opening a potential route for treating brain infections, tumors, and neurodegenerative diseases.
25Frontiers in Medical Technology. Exosome engineering for targeted therapy of brain-infecting pathogens: molecular tools, delivery platforms, and translational advancesCompared with synthetic nanoparticles like lipid nanoparticles (the technology behind mRNA vaccines), exosomes offer a natural membrane that cells recognize and tolerate. They engage receptors, modulate immune responses, and transfer cargo through biological pathways that synthetic particles cannot easily replicate. The trade-off is consistency: exosomes are inherently variable, harder to produce at scale, and more difficult to characterize batch to batch.
26Cambridge Materials: Health. Lipid nanoparticles versus exosome-based systems for central nervous system therapeutics: A translational perspectiveHow Exercise Changes Your Exosomes
Your body’s exosome output is not fixed. Physical activity rapidly alters both the number and content of exosomes circulating in the blood. In studies of people with type 2 diabetes, exercise increased the levels of a protective antioxidant enzyme (SOD3) in plasma exosomes after just a single bout. In mice with diabetes, two weeks of voluntary running restored the ability of circulating exosomes to promote blood vessel growth, an effect that was impaired by the disease.
27PubMed Central. Exercise improves angiogenic function of circulating exosomes in type 2 diabetes: Role of exosomal SOD3Skeletal muscle itself appears to be a major source of exercise-induced exosomes. Twelve weeks of swimming training in mice improved glucose tolerance, reduced fat buildup around organs, and slowed plaque formation in arteries. When researchers blocked exosome production from muscle, those benefits were partially lost, suggesting that muscle-derived exosomes carry proteins related to fat burning and mitochondrial function that reprogram metabolism elsewhere in the body.
28PubMed Central. Exercise Improves Metabolism and Alleviates Atherosclerosis via Muscle-Derived Extracellular VesiclesBody weight also matters independently of fitness level. In humans, higher BMI was associated with greater oxidative stress markers within circulating exosomes after exercise, while normal-weight individuals showed a more robust antioxidant response. In other words, the exosome response to exercise is not uniform: it depends on your starting metabolic state.
29PubMed Central. Impact of BMI and Cardiorespiratory Fitness on Oxidative Stress in Plasma and Circulating Exosomes Following Acute ExercisePlant-Derived Exosome-Like Particles
Exosome biology is not limited to animals. Plants produce structurally similar nanoparticles, often called plant-derived exosome-like nanoparticles, that carry microRNAs and other bioactive molecules. What makes these particles fascinating is that they appear to function across kingdoms of life. Plant microRNAs are chemically modified in a way that protects them from degradation in the human gut, allowing them to survive digestion and potentially enter mammalian cells.
30PubMed Central. Plant-Derived Exosome-Like Nanoparticles: Mechanisms of Cross-Kingdom Regulation and Perspectives as Natural Drug Carriers for Disease TreatmentStudies have shown that microRNAs from these plant particles can modulate pathways related to inflammation, cancer, and metabolism once inside mammalian cells. Whether this cross-kingdom communication plays a meaningful role in the health effects of a plant-rich diet is still debated, but the ability itself is well documented enough that researchers are exploring plant exosome-like particles as natural, low-cost drug carriers.
31PubMed Central. Exploring the bioactivity of MicroRNAs Originated from Plant-derived Exosome-like Nanoparticles (PELNs): current perspectivesWhy Manufacturing Exosomes at Scale Is So Difficult
For all the promise, getting exosome-based therapies into clinics requires solving problems that do not exist with conventional drugs. Exosomes are biological products, meaning every batch reflects the living cells that made them. Small changes in culture conditions, cell passage number, or growth media composition can shift exosome quantity and content. Purification adds another layer of difficulty: common methods include ultracentrifugation, ultrafiltration, size-exclusion chromatography, and immunocapture, each with trade-offs in purity, yield, and the risk of damaging the vesicles.
32PubMed Central. A Review of Exosomal Isolation Methods: Is Size Exclusion Chromatography the Best Option?Storing exosomes without losing their function is another unsolved challenge. Freezing can damage membranes; lyophilization (freeze-drying) requires stabilizing agents whose long-term effects on cargo integrity are still being studied. And because no regulatory agency has yet published definitive manufacturing guidelines specifically for exosome therapeutics, companies developing these products must negotiate standards on a case-by-case basis with regulators.
33PubMed Central. Manufacturing Therapeutic Exosomes: from Bench to IndustryScalability compounds all of these issues. Producing enough clinical-grade exosomes for large trials, let alone commercial distribution, requires bioreactor systems and purification workflows that are still being optimized. Harmonized protocols for characterizing what is actually in a given batch, and proving batch-to-batch consistency, remain works in progress across the field.
34Chinese Journal of Plastic and Reconstructive Surgery. Recent advances in scalable exosome production: Challenges and innovationsExosomes and Cardiovascular Health
The cardiovascular system offers one of the clearest illustrations of how exosomes can be both markers and drivers of disease. In patients with coronary artery disease and in those with type 2 diabetes, the number of vesicles shed from endothelial cells (the cells lining blood vessels) correlates with how poorly those blood vessels function. But the relationship is not just observational. Vesicles isolated from people with diabetes have been shown to directly impair the ability of blood vessels to relax, partly by reducing nitric oxide production and increasing oxidative stress.
35Journal of Endocrinology. Microvesicles and exosomes: new players in metabolic and cardiovascular diseaseThis creates a feedback loop: damaged vessels shed more vesicles, and those vesicles further damage vessels. Breaking that cycle is one of the goals motivating research into exercise-induced exosomes, which appear to carry cargo with the opposite effect, promoting vessel health and reducing oxidative damage. Whether exosome-based interventions can be harnessed therapeutically for cardiovascular protection remains an open question, but the biological rationale is compelling.